Table 1 Age, clinical presentation and pathologic characteristics from 76 patients diagnosed with penile cancer
From: Prevalence of human papillomavirus in penile malignant tumors: viral genotyping and clinical aspects
Age at diagnosis | N | % |
|---|---|---|
Average age | 60.6 ± 17.10 | - |
26-45 | 16 | 21.05 |
46-55 | 12 | 15.79 |
56-65 | 16 | 21.05 |
66-97 | 32 | 42.11 |
Lesion area | ||
Glans add other regions | 50 | 65.79 |
Foreskin | 08 | 10.53 |
Corpus | 03 | 3.95 |
Non evaluable | 15 | 19.74 |
Predominant morphology | ||
Ulceration | 17 | 22.37 |
Vegetating | 26 | 34.21 |
Ulceration and Vegetating | 17 | 22.37 |
Nodule and Vegetating | 01 | 1.32 |
Non evaluable | 16 | 21.05 |
Size of the lesion (cm) | ||
≤0,5 | 00 | 00 |
06-2,0 | 20 | 26.32 |
2,1-5,0 | 40 | 52.63 |
≥5,1 | 14 | 18.42 |
Non evaluable | 02 | 2.63 |
Staging of Jackson 1966 | ||
Stage I | 33 | 43.42 |
Stage II | 16 | 21.05 |
Stage III | 11 | 14.48 |
Stage IV | 16 | 21.05 |
Broders’ Classification | ||
Grade I | 26 | 34.21 |
Grade II | 36 | 47.37 |
Grade III | 06 | 7.89 |
Non evaluable | 08 | 10.53 |
Invasion | ||
Present | 18 | 23.69 |
Absent | 58 | 76.31 |
Infiltration | ||
Corpus add other regions | 24 | 31.58 |
Perineural | 01 | 1.32 |
Urethra | 03 | 3.95 |
Stroma | 03 | 3.95 |
Urethra and Stroma | 01 | 1.32 |
Absent | 44 | 57.89 |
Lymph node involvement | ||
Present | 15 | 19.73 |
Absent | 61 | 80.27 |
Lymphatic embolization | ||
Present | 04 | 5.26 |
Absent | 72 | 94.74 |
Inflammatory process | ||
Present | 16 | 21.05 |
Absent | 60 | 78.95 |